SCHEMBL27708554

SCHEMBL27708554

CNc1c(C)nn(C)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 3/20 0.39
HTT P42858 3/20 0.39
CYP3A4 P08684 2/20 0.39
GALR3 O60755 2/20 0.39
KDM4E B2RXH2 2/20 0.36
RECQL P46063 1/20 0.35
GAA P10253 1/20 0.35
LMNA P02545 2/20 0.35
NMT1 P30419 1/20 0.34
ALDH1A1 P00352 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762265 0.75 GAA (0.46) SMN1; SMN2L3MBTL1HTTKDM4EGAA
Hydrochloric Acid SCHEMBL28062471 0.73 GAA (0.48) SMN1; SMN2L3MBTL1HTTKDM4EGAA
SCHEMBL1632255 0.72
SCHEMBL1086373 0.72
SCHEMBL19313228 0.71 PKM (0.44) SMN1; SMN2HTTGALR3KDM4EGAA
SCHEMBL6911336 0.70
SCHEMBL26789810 0.69 TSHR (0.53) SMN1; SMN2L3MBTL1CYP1A2CYP2C19HTT
SCHEMBL5540323 0.68
Hydrochloric Acid SCHEMBL11544165 0.68 L3MBTL1 (0.40) SMN1; SMN2L3MBTL1KDM4EGAAALDH1A1
SCHEMBL18500604 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101133026-B 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus HOFFMANN LA ROCHE 2011-07-06 CN disclosed
CN-101133026-A 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus HOFFMANN LA ROCHE (CH) 2008-02-27 CN disclosed